Your Gulf file: search another company
Gulf file
BAXTER ONCOLOGY GmbH
Germany
Read 20 Oct 2026 from the SFDA drug company register and the EDE medicines directory. Is this your company, and is something wrong? Tell us.
Saudi Arabia
- Register entry
- BAXTER ONCOLOGY GMBH - GERMANY
- SFDA status
- Registered
- Registration
- 1990/16
- Type
- human medicines
- Production lines
- 4
Show
AMPOULE; ASEPTICALLY PREP. - LYOPHILISATES - HIGH POTENT; BIOLOGICAL PRODUCTS - IMMUNOLOGICAL PRODUCTS; VIAL
- Source
- SFDA register page
117 tenders from Saudi government health buyers are open today (16 NUPCO, 101 Etimad). The tender watch checks each new one against your products and tells you which your agent can bid.
United Arab Emirates
- Entries in the directory
- 1
- Classes
- Biological Medicines
- First registered
- 6 Jan 2008
- UAE agents
- CITY MEDICAL STORE - SOLE PROPRIETORSHIP L.L.C (1)
The second-agent rule applies to you. Since 24 Feb 2026 the EDE requires more than one authorised agent per medical product. Every one of your 1 directory entries goes through one agent.
UAE products
| Product | Form | Class | Dispensing | Registered | Agent |
|---|---|---|---|---|---|
| Abraxane® 100 mg/20 ml | Injection | Biological Medicines | Prescription Only Medicine (POM) | 6 Jan 2008 | CITY MEDICAL STORE - SOLE PROPRIETORSHIP L.L.C |
Names and entries exactly as the EDE directory lists them. The directory listed 1,179 products on 20 Oct 2026 and is still being loaded, so treat counts as a floor.